$82MSeries A, 22 January 2026
Launch financing to acquire and develop an initial rare disease asset portfolio.
- Amount
- $82M
- Stage
- Series A
- Announced
- 22 January 2026
- Lead
- OrbiMed
- Other investors
- 8VC, 5AM Ventures, Lux Capital, Wing VC
- Use of funds
- Launch financing to acquire and develop an initial rare disease asset portfolio.
- Checked
- Announced by the company
- Sources
- Mendra launches with $82M Series A businesswire.com
Mendra launches with $82M Series A pulse2.com